Gerardo García González is a Mexican microbiologist specializing in bacterial pathogenesis, phage therapy, and probiotic interactions. He completed his undergraduate studies at the Universidad de Sonora and earned both his Master's and Ph.D. in Science from the Universidad Autónoma de Nuevo León. His research focuses on understanding emerging bacterial infections in cystic fibrosis, developing phage-based therapies for antibiotic-resistant diseases, and studying the mechanisms through which probiotic bacteria interact with the host to promote health. Dr. García González has published significant work on bacteriophage isolation, recombinant protein expression in Pichia pastoris, and bacterial serine proteases. His research also covers bacterial resistance and molecular epidemiology, contributing to better clinical understanding and new therapeutic possibilities. Dr. García González is currently a professor and researcher at the Universidad Autónoma de Nuevo León, continuing to advance medical microbiology and biotechnology. His work has earned international recognition, and he remains an influential figure in the scientific community.
Gerardo García González is a Mexican microbiologist specializing in bacterial pathogenesis, phage therapy, and probiotic interactions. He completed his undergraduate studies at the Universidad de Sonora and earned both his Master's and Ph.D. in Science from the Universidad Autónoma de Nuevo León. His research focuses on understanding emerging bacterial infections in cystic fibrosis, developing phage-based therapies for antibiotic-resistant diseases, and studying the mechanisms through which probiotic bacteria interact with the host to promote health. Dr. García González has published significant work on bacteriophage isolation, recombinant protein expression in Pichia pastoris, and bacterial serine proteases. His research also covers bacterial resistance and molecular epidemiology, contributing to better clinical understanding and new therapeutic possibilities. Dr. García González is currently a professor and researcher at the Universidad Autónoma de Nuevo León, continuing to advance medical microbiology and biotechnology. His work has earned international recognition, and he remains an influential figure in the scientific community.